Arterial Interventions and Peripheral Arterial Disease (PAD)

Best CLI trial

Tuesday, March 7, 2023

5:00 PM – 6:00 PM

Location: Phoenix Convention Center, 231AB

CE: 1.0 Credit

Coordinator(s)

Srini Tummala, MD FSIR FSVM

Founder & Director Vascular Disease
Florida Vascular Specialists

Disclosure(s): Abbott Vascular: Consultant (Ongoing), Speaking and Teaching (Ongoing); CARDIOVASCUAR SYSTEMS (CSI): Consultant (Ongoing), Speaking and Teaching (Ongoing); Philips Image Guided Therapies: Consultant (Ongoing); Terumo Medical Corporation: Consultant (Ongoing)
Robert A. Lookstein, MD

Executive Vice Chair; Diagnostic, Molecular, and Interventional Radiology
Icahn School of Medicine at Mount Sinai

Disclosure(s): No relevant disclosure to display

Panelist(s)

MC

Mary Costantino, MD, FSIR

Medical Director
Advanced Vascular Centers

Disclosure(s): CARDIOVASCUAR SYSTEMS (CSI), CORDIS/CARDINAL HEALTH, INARI MEDICAL INC., INTACT VASCULAR, MEDTRONIC, PHILIPS, VESPER: Independent Contractor (Ongoing); Medtronic: Small amount of stock (Ongoing); Merit: Small amount of stock (Ongoing); Moonrise: Ownership Interest (Ongoing)
KM

Kumar Madassery, MD

Associate Professor, Vascular and Interventional Radiology
Rush University Medical Center, Rush Oak Park

Disclosure(s): Abbott Vascular: Consultant (Ongoing); Cook Mediical: Consultant (Ongoing); Koninklijke Philips: Consultant (Ongoing); PENUMBRA INC: Consultant (Ongoing)
Sanjay Misra, MD, FSIR (he/him/his)

Interventional Radiology
Mayo Clinic & Foundation

Disclosure(s): No relevant disclosure to display
Bret N. Wiechmann, MD FSIR

Medical Director
Vascular & Interventional Physicians

Disclosure(s): Philips: Advisory Committee or Review Panel Member (Ongoing)

Disclosure(s):

Srini Tummala, MD FSIR FSVM: Abbott Vascular: Consultant (Ongoing), Speaking and Teaching (Ongoing); CARDIOVASCUAR SYSTEMS (CSI): Consultant (Ongoing), Speaking and Teaching (Ongoing); Philips Image Guided Therapies: Consultant (Ongoing); Terumo Medical Corporation: Consultant (Ongoing)

Robert A. Lookstein, MD: No relevant disclosure to display

Mary Costantino, MD, FSIR: CARDIOVASCUAR SYSTEMS (CSI), CORDIS/CARDINAL HEALTH, INARI MEDICAL INC., INTACT VASCULAR, MEDTRONIC, PHILIPS, VESPER: Independent Contractor (Ongoing); Medtronic: Small amount of stock (Ongoing); Merit: Small amount of stock (Ongoing); Moonrise: Ownership Interest (Ongoing)

Kumar Madassery, MD: Abbott Vascular: Consultant (Ongoing); Cook Mediical: Consultant (Ongoing); Koninklijke Philips: Consultant (Ongoing); PENUMBRA INC: Consultant (Ongoing)

Sanjay Misra, MD, FSIR: No relevant disclosure to display

Bret N. Wiechmann, MD FSIR: Philips: Advisory Committee or Review Panel Member (Ongoing)

This session will discuss the landmark RCT BEST-CLI Trial strengths and weaknesses and and how it impacts your PAD practice.

Learning Objectives:

Understand the strengths of the BEST-CLI Trial RCT.
Understand the weaknesses of the BEST-CLI Trial RCT.
Learn how the BEST-CLI Trial RCT impacts your PAD practice.